Is asthma over-diagnosed in Cyprus? A clinical study at the outpatient’s primary care level
- 28 September 2022
- journal article
- Published by Peertechz Publications Private Limited in Open Journal of Asthma
- Vol. 6 (1), 001-007
- https://doi.org/10.17352/oja.000017
Abstract
Background: Although asthma is a common disease accurate diagnosis is missing and it has been reported that often it is over or under-diagnosed. Aim: To investigate if a physician’s diagnosis of asthma in Cyprus is correct by using a structured algorithm at the outpatient primary care level. Subjects and Methods: Sixty adults with a self-reported physician diagnosis of asthma, mean age of 47,8 years (29 males and 31 females) were included in the study. Medical history and physical examination, pre-post bronchodilation spirometry and methacholine bronchial challenge test was used to confirm or rule out the diagnosis as well as a three months follow-up. In addition, the cost of treatment was estimated. Results: Sixteen subjects (27%) had a positive pre-post bronchodilation spirometric test and were considered asthmatics. In 9 out of the 44 remaining subjects a positive Methacholine provocation test confirmed the diagnosis of asthma. The rest of the subjects (n = 35) went into a 3 months observational period during which only 2 showed asthmatic symptoms and were considered asthmatics by a second methacholine test that confirmed the diagnosis. Therefore, a correct asthma diagnosis was established in only 27(45%) of subjects. The annual average cost of medication for asthma confirmed the group was 313 euro/patient (171-454, 95% CI) and the average 2-year unnecessary (asthma ruled-out group) cost of treatment was approximately 297 euro/patient. (179-415, 95% CI). Conclusions: Physician-diagnosed asthma overestimates the actual prevalence of disease in adults in Cyprus since it was shown that more than half of the participants did not have Asthma. These individuals consume unneeded medications at a significant cost. Thus, the correct diagnosis of Asthma should be made by using more specific tests starting at the primary care level.Keywords
This publication has 26 references indexed in Scilit:
- The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: A global synthesisAllergologia et Immunopathologia, 2012
- Global asthma prevalence in adults: findings from the cross-sectional world health surveyBMC Public Health, 2012
- Republished review: An update on contraindications for lung function testingHeart, 2011
- The burden of adult asthma in the United States: Evidence from the Medical Expenditure Panel SurveyJournal of Allergy and Clinical Immunology, 2011
- Negative methacholine challenge tests in subjects who report physician-diagnosed asthmaClinical & Experimental Allergy, 2010
- Risks of Long-Acting Beta-Agonists in Achieving Asthma ControlThe New England Journal of Medicine, 2009
- Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)Thorax, 2007
- The Assessment of Validity of Different Asthma Diagnostic Tools in AdultsJournal of Asthma, 2005
- Prior Diagnosis and Treatment of Patients With Normal Results of Methacholine Challenge and Unexplained Respiratory SymptomsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1996
- Diagnosis of Bronchial Asthma by Clinical EvaluationSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1983